External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home AOCC 2026
Roche and Genentech at

AOCC 2026

June 25 - June 27
Seoul, Korea
aocc2026.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
11:00 PM
Duration 59mins Seoul, Korea
Symptomatic Remission and Health-Related Quality of Life With Afimkibart Treatment for Moderately to Severely Active Ulcerative Colitis in the Phase IIb TUSCANY-2 Trial
Rupert W. Leong, Andres Yarur, Jessica R. Allegretti, Silvio Danese, Laurent Peyrin-Biroulet, Daniela Bojic, Karen Lasch, Courtney Schiffman, Jinglan Pei, Anindita Banerjee, Deepa E. Chandra, Elena Peeva, Srividya Neelakantan, Michael S. Vincent, Vipul Jairath
Gastroenterology | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 59mins Seoul, Korea
Indirect Comparison of Afimkibart and Adalimumab Treatment Effects Using Data From TUSCANY-2 and HIBISCUS in Patients With Ulcerative Colitis
Xiang Gao, Qixiang Xu, Vishal A. Manickam, Yihao Li, Steven Levitte, Jiameng Zhang, K. T. Park
Gastroenterology | Inflammatory Bowel Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.